The EBMT/EHA CAR-T Cell Handbook

1. Auflage 2022
ISBN: 978-3-030-94352-3
Verlag: Springer

Buch, Englisch, 237 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 427 g

This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its  application in clinical care, to enhance readers’ knowledge and practice skills.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Kröger, Nicolaus

Gribben, John

Chabannon, Christian

Yakoub-Agha, Ibrahim

Einsele, Hermann

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pflege Krankenpflege
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin

Inhaltsverzeichnis

1. Introduction.- 2. The science behind CAR-T Cells.- 3. Manufacturing CAR-T Cells: the supply chain.- 4. Clinical indications for CAR-T Cells.- 5. Clinical management of patients treated with CAR-T Cells.- 6. Access to CAR-T cells.

Über Autor(innen)

Nicolaus Kröger  MD, is the current EBMT President, Professor of Medicine and Medical Director of the Department of Stem Cell Transplantation at the University Medical Center, Hamburg - Eppendorf, Germany 

John G. Gribben,  MD DSc FRCP FRCPath, FMedSci, is the Past President of EHA, Professor of Medical Oncology and Director of Stem Cell Transplantation at Saint Bartholomew's Hospital, Queen Mary School of Medicine, University of London, UK

Christian Chabannon,  MD, PhD, is the current chair of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT, is the Head and Qualified Person of the Cell Collection and Cell Processing Facility at Institut Paoli-Calmettes, the Coordinator of the "Centre d’Investigations Cliniques en Biothérapies de Marseille", and a Professor of Cell Biology at Aix-Marseille University, France

Ibrahim Yakoub-Agha,  MD, PhD, is the current chair of the Chronic Malignancies Working Party of the EBMT and holds the position of coordinating professor for the Department of Hematology at Lille Faculty of Medicine, France

Hermann Einsele,  MD, FRCP, is Full Professor of Internal Medicine and has been Director of the Department of Internal Medicine II of the University Hospital Würzburg, Germany